Cetera Advisor Networks’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Cetera Advisor Networks’s Portfolio FTXH Stock Details FTXH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-13,491	Closed	-$352K	–	2642
2023 Q1	$352K	Buy	13,491 +1,411	+12%	+$37.8K	﹤0.01%	1937
2022 Q4	$331K	Buy	12,080 +1,060	+10%	+$28.2K	﹤0.01%	1925
2022 Q3	$265K	Buy	+11,020	New	+$285K	﹤0.01%	1679
2020 Q3	–	Sell	-883	Closed	-$20K	–	1879
2020 Q2	$20K	Buy	+883	New	+$19.6K	﹤0.01%	2383

Other funds holding FTXH

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

WFA

WMG Financial Advisors Knoxville, Tennessee $265M AUM 26.03% 1-Year Est. Return

KNW

Kesler Norman & Wride Ogden, Utah $631M AUM 27.63% 1-Year Est. Return

PPWM

Paragon Private Wealth Management Lexington, Kentucky $320M AUM 23.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

OMC

Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Cetera Advisor Networks's FTXH Position: Q2 2023 in Review

Cetera Advisor Networks sold out of First Trust Nasdaq Pharmaceuticals ETF (FTXH) in Q2 2023, closing a stake of 13,491 shares — an estimated $352K sold.

Cetera Advisor Networks first reported a position in FTXH in Q2 2020 and held it in 4 quarters. The position peaked at $352K in Q1 2023. 25 funds tracked by Wall St. Rank hold FTXH as of Q2 2023.

Cetera Advisor Networks reported no remaining First Trust Nasdaq Pharmaceuticals ETF position as of Q2 2023 after selling out during the quarter.
Cetera Advisor Networks sold 13,491 First Trust Nasdaq Pharmaceuticals ETF shares in Q2 2023, an estimated $352K.
Cetera Advisor Networks first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q2 2020 and held it in 4 quarters.
Cetera Advisor Networks's First Trust Nasdaq Pharmaceuticals ETF position peaked at $352K in Q1 2023.
25 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q2 2023.

Based on Cetera Advisor Networks's 13F filing for Q2 2023, filed 10 Aug 2023.